The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
暂无分享,去创建一个
[1] H. Jenkins,et al. Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis , 2016, BMC Infectious Diseases.
[2] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[3] C. Dye,et al. Trends in tuberculosis incidence and their determinants in 134 countries. , 2009, Bulletin of the World Health Organization.
[4] G. Cauthen,et al. Annual risk of tuberculous infection. 1988. , 2002, Bulletin of the World Health Organization.
[5] R. Chaisson,et al. Latent Mycobacterium tuberculosis infection. , 2015, The New England journal of medicine.
[6] P. Dodd,et al. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. , 2014, The Lancet. Global health.
[7] M Elizabeth Halloran,et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics , 2009, Proceedings of the National Academy of Sciences.
[8] J. Janssens,et al. An ecological analysis of incidence of tuberculosis and per capita gross domestic product , 2008, European Respiratory Journal.
[9] Christopher Gilpin,et al. WHO's new End TB Strategy , 2015, The Lancet.
[10] P. Kouw,et al. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. , 2014, American journal of respiratory and critical care medicine.
[11] T. Robinson,et al. Sustainable Development Goals , 2016 .
[12] F. van Leth,et al. Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule. , 2008, Bulletin of the World Health Organization.
[13] B. Ghassemieh,et al. The Prevalence of Latent Tuberculosis Infection in the United States. , 2016, American journal of respiratory and critical care medicine.
[14] Christopher Dye,et al. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .
[15] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[16] A. Dirksen,et al. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. , 2002, The Journal of infectious diseases.
[17] P E Fine,et al. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection , 1997, Epidemiology and Infection.
[18] M. Pai,et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[19] R. Wilkinson,et al. The ongoing challenge of latent tuberculosis , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[20] Masahiro Narita,et al. Revisiting rates of reactivation tuberculosis: a population-based approach. , 2010, American journal of respiratory and critical care medicine.
[21] Elena Losina,et al. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] C. Dye,et al. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.
[23] C. Sismanidis,et al. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. , 2016, The Lancet. Infectious diseases.
[24] S. P. Akpabio. World Health Organisation , 1983, British Dental Journal.
[25] M. Pai,et al. Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.
[26] G. Weisenborn. United Nations Sustainable Development Goals , 2018 .
[27] Guidelines on the management of latent tuberculosis infection , 2014 .
[28] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[29] S. Radhakrishna,et al. The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. , 1982, Tubercle.
[30] S. Ferebee,et al. A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS. , 1963, The American review of respiratory disease.